333 related articles for article (PubMed ID: 8879197)
1. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.
Kersh GJ; Allen PM
J Exp Med; 1996 Oct; 184(4):1259-68. PubMed ID: 8879197
[TBL] [Abstract][Full Text] [Related]
2. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
Donermeyer DL; Weber KS; Kranz DM; Allen PM
J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
[TBL] [Abstract][Full Text] [Related]
3. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
Bhayani H; Paterson Y
J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
[TBL] [Abstract][Full Text] [Related]
4. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
5. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional consequences of altering a peptide MHC anchor residue.
Kersh GJ; Miley MJ; Nelson CA; Grakoui A; Horvath S; Donermeyer DL; Kappler J; Allen PM; Fremont DH
J Immunol; 2001 Mar; 166(5):3345-54. PubMed ID: 11207290
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
[TBL] [Abstract][Full Text] [Related]
8. Molecular components of T-cell recognition.
Jorgensen JL; Reay PA; Ehrich EW; Davis MM
Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
[TBL] [Abstract][Full Text] [Related]
9. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.
Hemmer B; Pinilla C; Gran B; Vergelli M; Ling N; Conlon P; McFarland HF; Houghten R; Martin R
J Immunol; 2000 Jan; 164(2):861-71. PubMed ID: 10623833
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the antigen binding site on the T cell receptor alpha chain.
Nalefski EA; Kasibhatla S; Rao A
J Exp Med; 1992 Jun; 175(6):1553-63. PubMed ID: 1588281
[TBL] [Abstract][Full Text] [Related]
11. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
Hsu BL; Donermeyer DL; Allen PM
J Immunol; 1996 Sep; 157(6):2291-8. PubMed ID: 8805626
[TBL] [Abstract][Full Text] [Related]
12. The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.
Danska JS; Livingstone AM; Paragas V; Ishihara T; Fathman CG
J Exp Med; 1990 Jul; 172(1):27-33. PubMed ID: 1694219
[TBL] [Abstract][Full Text] [Related]
13. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.
Moudgil KD; Grewal IS; Jensen PE; Sercarz EE
J Exp Med; 1996 Feb; 183(2):535-46. PubMed ID: 8627165
[TBL] [Abstract][Full Text] [Related]
14. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
15. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.
Evavold BD; Williams SG; Hsu BL; Buus S; Allen PM
J Immunol; 1992 Jan; 148(2):347-53. PubMed ID: 1370311
[TBL] [Abstract][Full Text] [Related]
16. On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).
Candia M; Kratzer B; Pickl WF
Int Arch Allergy Immunol; 2016; 170(4):211-233. PubMed ID: 27642756
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the strength of ligand antagonism in TCR triggering.
Van Den Berg HA; Burroughs NJ; Rand DA
Bull Math Biol; 2002 Jul; 64(4):781-808. PubMed ID: 12216421
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
19. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR.
Basu D; Horvath S; Matsumoto I; Fremont DH; Allen PM
J Immunol; 2000 Jun; 164(11):5788-96. PubMed ID: 10820257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
